Telehealth providers in South Dakota
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
Telehealth prescribing is allowed in South Dakota. What South Dakota requires of telehealth prescribers and pharmacies, plus verified listings.
South Dakota at a glance
- Pharmacy regulator
- South Dakota Board of Pharmacy (South Dakota Department of Health)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified telehealth providers serving South Dakota
No verified telehealth providers serving South Dakota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Telehealth prescribing rules in South Dakota
SDCL chapter 34-52 (Telehealth Utilization by Health Care Professionals, enacted 2021) defines telehealth to include interactive audio-video, audio combined with store-and-forward technology, and remote monitoring, and it defines store-and-forward as information stored for asynchronous delivery of care. The professional must be licensed in South Dakota (or work for a qualifying facility), and telehealth may not be used without a proper provider-patient relationship, which under SDCL 34-52-3 includes verifying the patient's identity, disclosing the provider's credentials, obtaining consent, establishing a diagnosis through examination and any needed testing, discussing treatment options, arranging follow-up, and using technology adequate to evaluate the condition. SDCL 34-52-6 bars prescribing a controlled substance solely in response to an internet questionnaire or telephone consult without such a relationship; GLP-1 medicines and the peptides in this database are not controlled, but the examination element of 34-52-3 still applies. Whether a purely asynchronous encounter can establish the relationship is not expressly resolved, so this record marks it as unresolved. [2]
Compounded GLP-1 access in South Dakota
South Dakota has not published a state rule that is looser than FDA policy. Because many South Dakota patients use mail order, confirming that the dispensing pharmacy holds a South Dakota nonresident license is the main practical check. [1] [3] [7]
Research use only sellers in South Dakota
SDCL chapter 36-11 reserves dispensing of prescription drugs to licensed pharmacies and pharmacists, so shipping "research use only" injectable peptides to South Dakota consumers is not a licensed pharmacy activity. [3] [8]
How to check a telehealth provider in South Dakota
- Confirm the prescriber is licensed or registered to treat patients located in South Dakota; the telehealth rules above explain what South Dakota requires. [2]
- Ask which pharmacy will fill the prescription and check it in the South Dakota Board of Pharmacy (South Dakota Department of Health) license lookup. [1] [3] [4] [5] [6]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Dakota. [3] [8]
Common questions in South Dakota
Can I get a GLP-1 prescription in South Dakota through telehealth?
Yes, from a provider licensed in South Dakota who first establishes a proper provider-patient relationship under SDCL 34-52-3. That relationship requires identity verification, consent, a diagnosis based on examination and any needed tests, a discussion of options, and follow-up care. [2]
Does South Dakota allow prescribing from an online questionnaire?
SDCL 34-52-6 expressly bars prescribing a controlled substance solely from an internet questionnaire or telephone consult without an established relationship. GLP-1 drugs are not controlled, but SDCL 34-52-3 still requires an examination-based diagnosis, so a questionnaire-only model is unlikely to meet South Dakota's standard. [2]
Does an out-of-state pharmacy need a South Dakota license to ship me compounded peptides?
Yes. SDCL 36-11-19.2 and 36-11-19.3 define nonresident pharmacies and require them to be licensed by the South Dakota Board of Pharmacy, with proof of good standing in their home state. Check the Board's license lookup before ordering. [1] [3] [4]
Sources
- [1]South Dakota Board of Pharmacy (South Dakota Department of Health)
- [2]South Dakota Codified Laws chapter 34-52, Telehealth utilization by health care professionals
- [3]South Dakota Codified Laws chapter 36-11, Pharmacists and pharmacies (including nonresident pharmacy licensure, 36-11-19.2 and 36-11-19.3)
- [4]South Dakota Codified Laws 36-11-19.3, Nonresident pharmacy licensure
- [5]Administrative Rules of South Dakota chapter 20:51:31, Compounding practices (amended effective September 15, 2025)
- [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [7]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [8]21 U.S.C. 331, Prohibited acts